These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23437987)

  • 41. The effect of statins on the recurrence rate of atrial fibrillation after catheter ablation: A meta-analysis.
    Peng H; Yang Y; Zhao Y; Xiao H
    Pacing Clin Electrophysiol; 2018 Nov; 41(11):1420-1427. PubMed ID: 30191566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablation.
    Li M; Liu T; Luo D; Li G
    Cardiol J; 2014; 21(1):89-95. PubMed ID: 23990188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is Atrial Fibrillation Noninducibility by Burst Pacing After Catheter Ablation Associated With Reduced Clinical Recurrence?: A Systematic Review and Meta-Analysis.
    Liu H; Yuan P; Zhu X; Fu L; Hong K; Hu J
    J Am Heart Assoc; 2020 Jul; 9(14):e015260. PubMed ID: 32654581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation in women.
    Zhang XD; Tan HW; Gu J; Jiang WF; Zhao L; Wang YL; Liu YG; Zhou L; Gu JN; Liu X
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1236-44. PubMed ID: 23822135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up.
    Naruse Y; Tada H; Sekiguchi Y; Machino T; Ozawa M; Yamasaki H; Igarashi M; Kuroki K; Itoh Y; Murakoshi N; Yamaguchi I; Aonuma K
    Heart Rhythm; 2011 Mar; 8(3):335-41. PubMed ID: 21056121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study).
    Tedrow UB; Conen D; Ridker PM; Cook NR; Koplan BA; Manson JE; Buring JE; Albert CM
    J Am Coll Cardiol; 2010 May; 55(21):2319-27. PubMed ID: 20488302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary veins to left atrium cycle length gradient predicts procedural and clinical outcomes of persistent atrial fibrillation ablation.
    Pascale P; Shah AJ; Roten L; Scherr D; Komatsu Y; Ramoul K; Daly M; Denis A; Derval N; Sacher F; Hocini M; Jaïs P; Haïssaguerre M
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):473-82. PubMed ID: 24829252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Meeder J; Kurpesa M; Baluta MM; Proietti M; Tavazzi L; Maggioni AP; Lip GYH;
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):566-572. PubMed ID: 29345382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum sRANKL/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation.
    Cao H; Wu Y; Li Q; Wu Y; Zhou Q; Røe OD; Chen Y; Wang R; Wang D
    Int J Cardiol; 2014 Jan; 170(3):298-302. PubMed ID: 24326209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation of obesity to recurrence rate and burden of atrial fibrillation.
    Guglin M; Maradia K; Chen R; Curtis AB
    Am J Cardiol; 2011 Feb; 107(4):579-82. PubMed ID: 21195377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation.
    Shoemaker MB; Muhammad R; Farrell M; Parvez B; White BW; Streur M; Stubblefield T; Rytlewski J; Parvathaneni S; Nagarakanti R; Roden DM; Saavedra P; Ellis C; Whalen SP; Darbar D
    Am J Cardiol; 2013 Feb; 111(3):368-73. PubMed ID: 23168290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renin-Angiotensin System Inhibitors for the Prevention of Atrial Fibrillation Recurrence After Ablation　- A Meta-Analysis.
    Peng L; Li Z; Luo Y; Tang X; Shui X; Xie X; Zheng Z; Dong R; Liu J; Zhu J; Li S
    Circ J; 2020 Sep; 84(10):1709-1717. PubMed ID: 32879151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefits and risks of additional ablation of complex fractionated atrial electrograms for patients with atrial fibrillation: a systematic review and meta-analysis.
    Wu SH; Jiang WF; Gu J; Zhao L; Wang YL; Liu YG; Zhou L; Gu JN; Xu K; Liu X
    Int J Cardiol; 2013 Oct; 169(1):35-43. PubMed ID: 24083885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes of AF patients treated with the first and second-generation of circular mapping and ablation catheter: insights from a real world multicenter experience.
    Rovaris G; De Filippo P; Laurenzi F; Zanotto G; Bottoni N; Pozzi M; Giofrè F; De Girolamo P; Visentin E; Piazzi E; Ferrari P
    J Interv Card Electrophysiol; 2017 Dec; 50(3):245-251. PubMed ID: 28875448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox.
    Grymonprez M; Capiau A; De Backer TL; Steurbaut S; Boussery K; Lahousse L
    Clin Cardiol; 2021 May; 44(5):599-608. PubMed ID: 33769583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis.
    Dentali F; Gianni M; Squizzato A; Ageno W; Castiglioni L; Maroni L; Hylek EM; Grandi AM; Cazzani E; Venco A; Guasti L
    Thromb Haemost; 2011 Aug; 106(2):363-70. PubMed ID: 21614408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.
    Papageorgiou N; Providência R; Srinivasan N; Bronis K; Costa FM; Cavaco D; Adragão P; Tousoulis D; Hunter RJ; Schilling RJ; Segal OR; Chow A; Rowland E; Lowe M; Lambiase PD
    Int J Cardiol; 2017 Jan; 227():151-160. PubMed ID: 27863291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Takagi K; Fujino T; Kimura S; Hikita H; Tomita M; Hirao K; Isobe M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):267-73. PubMed ID: 24610740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.